Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2022-03-16 Share Issue/Capital Cha…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Share capital increase registered
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces a 'Share capital increase registered' following the exercise of share options. It details the number of new shares issued (2,750) and the resulting total share capital and number of shares. This directly relates to a change in the company's capital structure, specifically the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). The document is short and is an announcement, but the content is a direct report of a capital change event, not just an announcement that a report is available, making SHA more specific than RPA or RNS.
2022-03-16 English
Photocure ASA: Share capital increase registered
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces a 'Share capital increase registered' following the exercise of share options. It details the number of new shares issued (2,750) and the resulting total share capital and number of shares. This directly relates to changes in the company's capital structure through the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). The document is short and is an announcement of a corporate action, not a comprehensive report.
2022-03-16 English
Photocure ASA: Exercise of employee share options and share capital increase
Share Issue/Capital Change Classification · 98% confidence The document explicitly details the exercise of employee share options and the subsequent increase in the company's share capital by issuing new shares. This directly relates to changes in the company's share structure and capital. Reviewing the definitions, 'Share Issue/Capital Change (Code: SHA)' is the most appropriate classification, as it covers announcements regarding new share issues or capital structure changes. It is not a Director's Dealing (DIRS) because no primary insiders exercised options, nor is it a general financing update (CAP), as it is specifically about the issuance of shares following option exercises.
2022-03-14 English
Photocure ASA: Exercise of employee share options and share capital increase
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'Exercise of employee share options and share capital increase'. It details the number of options exercised, the resulting issuance of 2,750 new shares, and the subsequent change in the company's share capital. This directly relates to changes in the company's capital structure through the issuance of new shares, which aligns perfectly with the definition of 'Capital/Financing Update' (CAP). While it involves shares, it is not a general share repurchase (POS) but a specific capital increase resulting from an option program. It is not a Director's Dealing (DIRS) as it explicitly states 'No primary insiders have exercised share options.' Therefore, CAP is the most appropriate classification.
2022-03-14 English
Photocure announces Endotherapeutics Group as New Commercial Partner for Hexvix in Australia & New Zealand
Regulatory Filings Classification · 100% confidence The document is titled "Photocure announces Endotherapeutics Group as New Commercial Partner for Hexvix in Australia & New Zealand" and is explicitly labeled as a "Press release" dated March 4, 2022. It details a change in a distribution agreement (termination of one, initiation of another) and provides quotes from management. This content—announcing a business partnership, distribution change, and corporate event—does not fit the definitions for financial reports (10-K, IR, ER), specific regulatory filings (DVA, DIRS), or meeting materials (AGM-R, DEF 14A). Since it is a general corporate announcement regarding business operations and partnerships, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory announcements that do not fit elsewhere, although it is very close to a general corporate news release.
2022-03-04 English
Photocure announces Endotherapeutics Group as New Commercial Partner for Hexvix in Australia & New Zealand
Regulatory Filings Classification · 100% confidence The document is a press release announcing a new exclusive distribution agreement between Photocure ASA and Endotherapeutics Group for Hexvix in Australia and New Zealand, and the termination of a previous agreement with Juno Pharmaceuticals. This type of announcement, detailing strategic business changes, partnerships, or commercial updates, is characteristic of a general corporate announcement. Since it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific report (like AR or IR), and it is not a proxy statement (DEF 14A) or a management discussion (MDA), the most appropriate classification is the general regulatory announcement/press release category, which is RNS (Regulatory Filings), as it serves as a broad communication to the market about a significant business event.
2022-03-04 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.